title: Extreme Duration of Diazepam-Associated Sedation in a Patient With Alcohol Delirium and CYP2C19 Polymorphisms.
authors.affiliation: Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden anna.garmen@karolinska.se Department of Emergency Medicine, Karolinska University Hospital, Stockholm, Sweden Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.
authors.forename: Anna K
authors.initials: AK
authors.lastname: Garmén
authors.forename: Nina
authors.initials: N
authors.lastname: Pettersson
authors.forename: Christian
authors.initials: C
authors.lastname: Unge
authors.forename: Jonatan D
authors.initials: JD
authors.lastname: Lindh
mesh_terms: D000368:Aged; D000430:Alcohol Withdrawal Delirium / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D065731:Cytochrome P-450 CYP2C19 / Q000235:genetics*; D003975:Diazepam / Q000009:adverse effects*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D008297:Male; D011110:Polymorphism, Genetic / Q000235:genetics*; D013997:Time Factors
chemical_list: D006993:Hypnotics and Sedatives; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D003975:Diazepam